Thymosin Alpha-1 (TA-1) 5mg

1 x 5mL at 3000 mcg/mL ready-to-inject subcutaneous.

“Thymosin Alpha 1: Biological activities, applications and engineering production Thymosin alpha 1 (Tal), a 28-amino acid peptide, was production of this peptide. So far, Tal used in clinic is first described and haracterized from calf thymuses in synthesized using solid phase peptide synthesis. Here, we 1977. This peptide can enhance T-cell, dendritic cell (DC) summarize the genetic engineering methods to produce and antibody responses, modulate cytokines and Tal using prokaryotic or eukaryotic expression systems. chemokines production and block steroid-induced The effectiveness of these biological products in increasing apoptosis of thymocytes.
Due to its pleiotropic biological the secretion of cytokines and in promoting lymphocyte activities, Tal has gained increasing interest in recent years proliferation were investigated in vitro studies. This opens and has been used for the treatment of various diseases the possibility for biotechnological production of Tal for in clinic. Accordingly, there is an increasing need for the the research and clinical applications. Li, Juan Jenny et al.
“”Thymosin alpha 1: Biological activities, applications and genetic engineering production.”” Peptides 31 (2010): 2151-2158.”